{"id":59625,"date":"2026-02-26T22:11:55","date_gmt":"2026-02-26T22:11:55","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/hunter-syndrome-treatment-market-mordor\/"},"modified":"2026-09-18T16:54:33","modified_gmt":"2026-09-18T07:54:33","slug":"hunter-syndrome-treatment-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/hunter-syndrome-treatment-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ud5cc\ud130\uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/hunter-syndrome-treatment-market_1666099011605_Hunter_Syndrome_Treatment_Market_-_major_players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/hunter-syndrome-treatment-market-size-image-1770820304914.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uac15\ub825\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c \ubc0f \uac00\uaca9 \uacb0\uc815\ub825<\/li>\n<li class=\"toc-level-3\">4.2.2 \ud655\ub300\ub418\ub294 \uc815\ubd80 \ud76c\uadc0\uc9c8\ud658 \uc9c0\uc6d0 \ud504\ub85c\uadf8\ub7a8<\/li>\n<li class=\"toc-level-3\">4.2.3 BBB \ud22c\uacfc\uc131 ERT(\uc608: \ud30c\ube44\ub098\ud478\uc2a4\ud504 \uc54c\ud30c)\uc758 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc<\/li>\n<li class=\"toc-level-3\">4.2.4 AAV9 \ubc0f LV \uae30\ubc18 \uc720\uc804\uc790 \uce58\ub8cc\uc81c \ud30c\uc774\ud504\ub77c\uc778 \uac00\uc18d\ud654<\/li>\n<li class=\"toc-level-3\">4.2.5 MPS II \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud328\ub110 \ud3ec\ud568<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc7ac\ud0dd \uc8fc\uc785 \uc11c\ube44\uc2a4 \ubaa8\ub378\uc758 \uc131\uc7a5<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uc5f0\uac04 \uce58\ub8cc \ube44\uc6a9 \ubc0f \uc0c1\ud658 \ub9c8\ucc30<\/li>\n<li class=\"toc-level-3\">4.3.2 IV ERT\uc758 \uc81c\ud55c\uc801\uc778 \uc911\ucd94\uc2e0\uacbd\uacc4 \ud6a8\ub2a5<\/li>\n<li class=\"toc-level-3\">4.3.3 \uadf9\ud788 \uc801\uc740 \ud658\uc790 \ud480\ub85c \uc778\ud55c \uc9c4\uc785 \uae30\uc5c5\uc758 ROI \uc81c\ud55c<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc735\ud569 \ub2e8\ubc31\uc9c8\uc758 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc870 \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ud6a8\uc18c \ub300\uccb4 \uc694\ubc95 (ERT)<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc870\ud608\ubaa8\uc138\ud3ec \uc774\uc2dd (HSCT)<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc720\uc804\uc790 \ubc0f \uae30\ud0c0 \ucca8\ub2e8 \uce58\ub8cc\ubc95<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ubcd1\uc6d0<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc9c4\ub2e8 \ubc0f \ucc38\uc870 \uc5f0\uad6c\uc18c<\/li>\n<li class=\"toc-level-3\">5.2.3 \uac00\uc815 \uc8fc\uc785 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.3.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.3.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.3.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.3.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.3.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.3.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.3.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.3.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.3.3.4 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.5 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.3.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.3.4.2 \ub0a8\uc544\ud504\ub9ac\uce74 \uacf5\ud654\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.3.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.3.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.3.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34, \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Takeda Pharmaceutical Company Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.2 GC Pharma (Green Cross Holdings)<\/li>\n<li class=\"toc-level-3\">6.3.3 JCR Pharmaceuticals Co. Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.4 REGENXBIO Inc.<\/li>\n<li class=\"toc-level-3\">6.3.5 Denali Therapeutics Inc.<\/li>\n<li class=\"toc-level-3\">6.3.6 Avrobio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.7 Sangamo Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.8 Esteve Pharma<\/li>\n<li class=\"toc-level-3\">6.3.9 Bioasis Technologies Inc.<\/li>\n<li class=\"toc-level-3\">6.3.10 Clinigen Group PLC<\/li>\n<li class=\"toc-level-3\">6.3.11 CANbridge Life Sciences Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.12 ISU Abxis Co. Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.13 Ultragenyx Pharmaceutical<\/li>\n<li class=\"toc-level-3\">6.3.14 Orchard Therapeutics plc<\/li>\n<li class=\"toc-level-3\">6.3.15 Passage Bio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.16 uniQure N.V.<\/li>\n<li class=\"toc-level-3\">6.3.17 Bluebird bio Inc.<\/li>\n<li class=\"toc-level-3\">6.3.18 Idorsia Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.19 Lysogene S.A.<\/li>\n<li class=\"toc-level-3\">6.3.20 ArmaGen Inc.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5 \uac1c\uc694 (2026-2031)<\/p>\n<p>\ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc740 2025\ub144 13\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2026\ub144 14\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud588\uc73c\uba70, 2031\ub144\uc5d0\ub294 5.24%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\ub85c 18\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uac15\ub825\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c, \ud608\ub1cc\uc7a5\ubcbd(BBB) \ud22c\uacfc \ud6a8\uc18c\ub300\uccb4\uc694\ubc95(ERT) \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc758 \uc2b9\uc778 \uac00\uc18d\ud654, \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud504\ub85c\uadf8\ub7a8\uc758 \uafb8\uc900\ud55c \ud655\ub300\uc5d0 \ud798\uc785\uc740 \uac83\uc785\ub2c8\ub2e4. \ud6a8\uc18c\ub300\uccb4\uc694\ubc95(ERT)\uc774 \uc5ec\uc804\ud788 \uc8fc\uc694 \uc218\uc775\uc6d0\uc774\ub098, \uc2e0\uacbd\ud559\uc801 \ud55c\uacc4\ub85c \uc778\ud574 \uc911\ucd94\uc2e0\uacbd\uacc4(CNS)\uc5d0 \uc9c0\uc18d\uc801\uc778 \uc774\uc810\uc744 \uc81c\uacf5\ud558\ub294 \uc544\ub370\ub178 \uad00\ub828 \ubc14\uc774\ub7ec\uc2a4(AAV) \ubc0f \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uac00 \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc18c\uaddc\ubaa8 \ud601\uc2e0 \uae30\uc5c5\ub4e4\uc774 \ub300\ud615 \uc81c\uc57d\uc0ac\uc640 \ud611\ub825\ud558\uc5ec \uc81c\uc870 \uaddc\ubaa8\uc640 \uc9c0\uc5ed\ubcc4 \uc0c1\uc5c5\uc801 \ub178\ud558\uc6b0\ub97c \ud655\ubcf4\ud558\uba74\uc11c \uacbd\uc7c1 \uac15\ub3c4 \ub610\ud55c \uc2ec\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, \uac00\uc815 \uc8fc\uc785 \ubaa8\ub378\uc740 \ud22c\uc5ec \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 \ud658\uc790 \ud3b8\uc758\uc131\uc744 \ud5a5\uc0c1\uc2dc\ucf1c \uc804\ubc18\uc801\uc778 \uc218\uc694\ub97c \uac15\ud654\ud558\uba70 \uc8fc\ubaa9\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\uc778 \ubc0f \uc5b5\uc81c \uc694\uc778<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\uc778:<\/p>\n<p>*   \uac15\ub825\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c \ubc0f \uac00\uaca9 \uacb0\uc815\ub825 (CAGR \uc601\ud5a5 +1.80%): \ud76c\uadc0\uc758\uc57d\ud488 \uc9c0\uc815\uc740 \ubbf8\uad6d\uc5d0\uc11c 7\ub144, \uc720\ub7fd\uc5d0\uc11c 10\ub144\uc758 \uc2dc\uc7a5 \ub3c5\uc810\uad8c\uc744 \ubd80\uc5ec\ud558\uc5ec \ub192\uc740 \uc5f0\uad6c\uac1c\ubc1c \ube44\uc6a9\uc744 \ud68c\uc218\ud560 \uc218 \uc788\uac8c \ud569\ub2c8\ub2e4. 2024\ub144 \ubbf8\uad6d \uc2e0\uc57d \uc2b9\uc778\uc758 80% \uc774\uc0c1\uc774 \ud2b9\uc218 \uc758\uc57d\ud488\uc774\uc5c8\uc73c\uba70, \uc6b0\uc120 \uc2ec\uc0ac \ubc14\uc6b0\ucc98(Priority Review Voucher)\ub294 \uaddc\uc81c \uac80\ud1a0 \uae30\uac04\uc744 \ub2e8\ucd95\uc2dc\ucf1c \ub9e4\ub825\uc744 \ub354\ud569\ub2c8\ub2e4. \uc778\ud50c\ub808\uc774\uc158 \uac10\ucd95\ubc95(IRA) \uc870\ud56d \uc644\ud654 \uc81c\uc548\uc740 \ud76c\uadc0\uc758\uc57d\ud488\uc5d0 \ub300\ud55c \uc785\ubc95 \uc9c0\uc6d0\uc744 \uc2dc\uc0ac\ud558\uba70, 2025-2030\ub144 \ub3d9\uc548 \uac00\uaca9 \uacb0\uc815\ub825\uc774 \ud06c\uac8c \uc57d\ud654\ub418\uc9c0 \uc54a\uc744 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc815\ubd80\uc758 \ud76c\uadc0 \uc9c8\ud658 \uc9c0\uc6d0 \ud504\ub85c\uadf8\ub7a8 \ud655\ub300 (CAGR \uc601\ud5a5 +1.20%): NIH\uc758 &#8220;\uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac00\ub2a5\ud55c \ud76c\uadc0 \uc9c8\ud658&#8221; \uc5f0\uad6c \uc9c0\uc6d0\uacfc \uc720\ub7fd\uc758 &#8220;\ud76c\uadc0 \uc720\uc804\uccb4 \uce58\ub8cc \uae30\uae08&#8221; \uc81c\uc548\uc740 \uc870\uae30 \uac1c\uc785\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<br \/>\n*   BBB \ud22c\uacfc ERT\uc758 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc (CAGR \uc601\ud5a5 +1.50%): Pabinafusp alfa\uc640 Denali Therapeutics\uc758 tividenofusp alfa\ub294 \uc784\uc0c1\uc801\uc73c\ub85c \uc720\uc758\ubbf8\ud55c CNS \uce68\ud22c\ub97c \uc785\uc99d\ud558\uba70 \uae30\uc874 IV ERT\uc758 \ud55c\uacc4\ub97c \uadf9\ubcf5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uacf5\uc740 \uc720\uc0ac\ud55c \uc735\ud569 \ub2e8\ubc31\uc9c8 \uc124\uacc4\uc758 \ucc44\ud0dd\uc744 \uac00\uc18d\ud654\ud560 \uac83\uc785\ub2c8\ub2e4.<br \/>\n*   AAV9 \ubc0f LV \uae30\ubc18 \uc720\uc804\uc790 \uce58\ub8cc\uc81c \ud30c\uc774\ud504\ub77c\uc778 \uac00\uc18d\ud654 (CAGR \uc601\ud5a5 +0.80%): REGENXBIO\uc758 RGX-121\uc740 \ub1cc\ucc99\uc218\uc561 \ud5e4\ud30c\ub780 \ud669\uc0b0\uc5fc\uc744 85% \uac10\uc18c\uc2dc\ud0a4\uace0 ERT \uc911\ub2e8\uc744 \uac00\ub2a5\ud558\uac8c \ud588\uc2b5\ub2c8\ub2e4. \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4 \uc870\ud608\ubaa8\uc138\ud3ec \uc811\uadfc\ubc95 \ub610\ud55c \uc6b0\uc218\ud55c \ud6a8\uc18c \ubc1c\ud604\uc744 \ubcf4\uace0\ud558\uace0 \uc788\uc73c\uba70, \ubca1\ud130 \uc81c\uc870 \ub2a5\ub825 \ud5a5\uc0c1\uc740 \ube44\uc6a9 \uc808\uac10\uc5d0 \uae30\uc5ec\ud569\ub2c8\ub2e4.<br \/>\n*   \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud328\ub110\uc5d0 MPS II \ud3ec\ud568 (CAGR \uc601\ud5a5 +0.60%): \ubd81\ubbf8 \ubc0f \uc720\ub7fd\uc744 \uc911\uc2ec\uc73c\ub85c MPS II\uac00 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud328\ub110\uc5d0 \ud3ec\ud568\ub418\uba74\uc11c \uc870\uae30 \uc9c4\ub2e8 \ubc0f \uce58\ub8cc\uac00 \uac00\ub2a5\ud574\uc838 \ud658\uc790 \ud480\uc774 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uac00\uc815 \uc8fc\uc785 \uc11c\ube44\uc2a4 \ubaa8\ub378\uc758 \uc131\uc7a5 (CAGR \uc601\ud5a5 +0.40%): \ubcd1\uc6d0 \ubc29\ubb38\uc758 \ud544\uc694\uc131\uc744 \uc904\uc5ec \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 \ud658\uc790 \ud3b8\uc758\uc131\uc744 \ub192\uc774\ub294 \uac00\uc815 \uc8fc\uc785 \ubaa8\ub378\uc774 \uac1c\ubc1c\ub41c \uc2dc\uc7a5\uc744 \uc911\uc2ec\uc73c\ub85c \ud655\uc0b0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc5b5\uc81c \uc694\uc778:<\/p>\n<p>*   \ub192\uc740 \uc5f0\uac04 \uce58\ub8cc \ube44\uc6a9 \ubc0f \ubcf4\ud5d8 \uc0c1\ud658 \ub9c8\ucc30 (CAGR \uc601\ud5a5 -1.50%): \ub9cc\uc131 IV ERT \uc694\ubc95\uc740 \uc5f0\uac04 40\ub9cc \ub2ec\ub7ec\ub97c \ucd08\uacfc\ud560 \uc218 \uc788\uc73c\uba70, \uc77c\ud68c\uc131 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\ub294 \uc7a5\uae30\uc801\uc778 \ube44\uc6a9 \uc0c1\uc1c4\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \ucd08\uae30 \uc608\uc0b0 \ubd80\ub2f4\uc774 \ud07d\ub2c8\ub2e4. \uc774\ub85c \uc778\ud574 \uc5c4\uaca9\ud55c \uc0ac\uc804 \uc2b9\uc778 \uc808\ucc28\uc640 \uc2e0\uacbd\ud559\uc801 \uc774\uc810 \uc785\uc99d \uc694\uad6c\uac00 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ub2a6\ucda5\ub2c8\ub2e4.<br \/>\n*   \uc815\ub9e5 \uc8fc\uc0ac ERT\uc758 \uc81c\ud55c\uc801\uc778 CNS \ud6a8\ub2a5 (CAGR \uc601\ud5a5 -0.80%): \ud608\ub1cc\uc7a5\ubcbd\uc73c\ub85c \uc778\ud574 \uc2e0\uacbd \uc870\uc9c1\uc73c\ub85c\uc758 \ud6a8\uc18c \uc804\ub2ec\uc774 \uc5b4\ub824\uc6cc \uc2ec\uac01\ud55c \ud45c\ud604\ud615 \ud658\uc790\uc758 \uc778\uc9c0 \uc800\ud558\ub97c \ub9c9\uae30 \uc5b4\ub835\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uae30\uc874 IV ERT\uc758 \uc7a5\uae30\uc801\uc778 \uae30\uc5ec\ub97c \uc81c\ud55c\ud569\ub2c8\ub2e4.<br \/>\n*   \ucd08\uc18c\ud615 \ud658\uc790 \ud480\ub85c \uc778\ud55c \ud22c\uc790 \uc218\uc775\ub960(ROI) \uc81c\ud55c (CAGR \uc601\ud5a5 -0.70%): \ub9e4\uc6b0 \uc801\uc740 \ud658\uc790 \uc218\ub294 \uc2e0\uaddc \uc9c4\uc785 \uae30\uc5c5\uc758 \ud22c\uc790 \uc218\uc775\ub960\uc744 \uc81c\ud55c\ud558\uc5ec \uc2dc\uc7a5 \uc9c4\uc785\uc744 \uc5b4\ub835\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \uc735\ud569 \ub2e8\ubc31\uc9c8\uc758 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc81c\uc870 \ubcd1\ubaa9 \ud604\uc0c1 (CAGR \uc601\ud5a5 -0.50%): \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ud074\ub9b0\ub8f8\uc758 \ub192\uc740 \uac00\ub3d9\ub960\uc740 \uc81c\uc870 \ub9ac\ub4dc \ud0c0\uc784\uc744 \uc9c0\uc5f0\uc2dc\ud0a4\uace0 \uacf5\uae09\uc5d0 \ubcd1\ubaa9 \ud604\uc0c1\uc744 \ucd08\ub798\ud569\ub2c8\ub2e4.<\/p>\n<p>\uce58\ub8cc \uc720\ud615\ubcc4 \ubd84\uc11d<\/p>\n<p>2025\ub144 \ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \ud6a8\uc18c\ub300\uccb4\uc694\ubc95(ERT)\uc740 Takeda\uc758 ELAPRASE\uac00 916\uc5b5 \uc5d4(6\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec)\uc758 \ub9e4\ucd9c\uc744 \uae30\ub85d\ud558\uba70 81.35%\uc758 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc720\uc804\uc790 \ubc0f \uae30\ud0c0 \ucca8\ub2e8 \uce58\ub8cc\ubc95\uc740 7.06%\uc758 CAGR\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uba70 2031\ub144\uae4c\uc9c0 \uc0c1\ub2f9\ud55c \uc2dc\uc7a5 \uc810\uc720\uc728 \ubcc0\ud654\ub97c \uc608\uace0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. RGX-121 \ucd08\uae30 \ud22c\uc5ec \ud658\uc790\ub4e4\uc740 \uc548\uc815\uc801\uc778 \uc801\uc751 \ud589\ub3d9 \ubc0f \uc6b4\ub3d9 \ubc1c\ub2ec\uc744 \ubcf4\uc600\uc73c\uba70, 80%\uac00 \uc8fc\uac04 ERT\ub97c \uc644\uc804\ud788 \uc911\ub2e8\ud588\uc2b5\ub2c8\ub2e4. \ubcd1\uc6d0\uacfc \ubcf4\ud5d8\uc0ac\ub294 \uc77c\ud68c\uc131 \uc8fc\uc785\uc758 \uc784\uc0c1\uc801, \ubb3c\ub958\uc801 \uc774\uc810\uc744 \uc778\uc2dd\ud558\uace0 \uc788\uc73c\uba70, \uc218\ubc31\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\ub294 \uac00\uaca9\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \ube60\ub978 \ucc44\ud0dd\uc744 \uc9c0\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. AAV9 \ubca1\ud130 \uc678\uc5d0\ub3c4 \ub80c\ud2f0\ubc14\uc774\ub7ec\uc2a4 \uc790\uac00 \uc904\uae30\uc138\ud3ec \uce58\ub8cc\ubc95\uc740 \uc870\uae30 \uc5f0\uad6c\uc5d0\uc11c \uc2e0\uacbd\ub3c5\uc131 \uc5c6\uc774 \uc0dd\ub9ac\uc801 \uc218\uc900 \uc774\uc0c1\uc758 \uc774\ub450\ub85c\ub124\uc774\ud2b8-2-\uc124\ud30c\ud0c0\uc81c \ubc1c\ud604\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4. \uc5fc\uae30 \ud3b8\uc9d1 \ubc0f CRISPR \ud50c\ub7ab\ud3fc\ub3c4 \ud3c9\uac00 \uc911\uc774\uc9c0\ub9cc \uc544\uc9c1 \uc804\uc784\uc0c1 \ub2e8\uacc4\uc5d0 \uc788\uc2b5\ub2c8\ub2e4. \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc81c\uc870 \ub2a5\ub825\uc740 \uc5ec\uc804\ud788 \ubcd1\ubaa9 \ud604\uc0c1\uc73c\ub85c \uc791\uc6a9\ud558\uc9c0\ub9cc, \uccab \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uac00 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc2b9\uc778\ub418\uba74 \ucca8\ub2e8 \uce58\ub8cc\ubc95 \uc2dc\uc7a5 \uaddc\ubaa8\ub294 \uae09\uaca9\ud788 \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4 \ubd84\uc11d<\/p>\n<p>2025\ub144 \ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \ubcd1\uc6d0\uc740 IV ERT \uc8fc\uc785\uc5d0 \ud544\uc694\ud55c \ubb34\uade0 \ud658\uacbd\uacfc \uc544\ub098\ud544\ub77d\uc2dc\uc2a4 \ub300\ube44\uc758 \ud544\uc694\uc131\uc73c\ub85c \uc778\ud574 66.65%\uc758 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uac00\uc815 \uc8fc\uc785 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9\uc740 \ubcf4\ud5d8\uc0ac\uac00 \uc2dc\uc124 \uac04\uc811\ube44\ub97c \uc904\uc774\ub824 \ud568\uc5d0 \ub530\ub77c 2031\ub144\uae4c\uc9c0 6.21%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ub3c5\uc77c \ucf54\ud638\ud2b8 \ub370\uc774\ud130\uc5d0 \ub530\ub974\uba74 ERT\ub97c \ubcd1\uc6d0\uc5d0\uc11c \uac04\ud638\uc0ac \uac10\ub3c5 \ud558\uc758 \uac00\uc815 \ud658\uacbd\uc73c\ub85c \uc804\ud658\ud588\uc744 \ub54c \uc694\ub85c \uae00\ub9ac\ucf54\uc0ac\ubbf8\ub178\uae00\ub9ac\uce78 \uc81c\uac70\uc728\uacfc \ud658\uc790 \ubcf4\uace0 \uacb0\uacfc \uc810\uc218\uac00 \ub3d9\uc77c\ud558\uac8c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. \uc720\uc804\uc790 \uce58\ub8cc\uc81c \ub3c4\uc785 \ucd08\uae30\uc5d0\ub294 \uc77c\ud68c\uc131 \uc8fc\uc785\uc5d0 \ub300\ud55c \uc7a5\uae30 \ubaa8\ub2c8\ud130\ub9c1 \ubc0f \ud2b9\uc218 \ubca1\ud130 \ucde8\uae09 \ud504\ub85c\ud1a0\ucf5c\ub85c \uc778\ud574 \ubcd1\uc6d0\uc758 \uc9c0\ubc30\ub825\uc774 \uc77c\uc2dc\uc801\uc73c\ub85c \ud68c\ubcf5\ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc8fc\uc785 \ud6c4 \ubc14\uc774\uc624\ub9c8\ucee4 \ucc44\ucde8 \ubc0f \uc2e0\uacbd\uc778\uc9c0 \ud3c9\uac00\ub97c \ud3ec\ud568\ud55c \ud6c4\uc18d \uad00\ub9ac\ub294 \uc9c0\uc5ed \uc804\ubb38 \ud074\ub9ac\ub2c9 \uc778\ud504\ub77c\uc640 \uc798 \ubd80\ud569\ud569\ub2c8\ub2e4. \uc7a5\uae30\uc801\uc73c\ub85c\ub294 \uc6d0\uaca9 \ud658\uc790 \ubaa8\ub2c8\ud130\ub9c1 \uae30\uc220\uc774 \uc131\uc219\ud558\uace0 \uaddc\uc81c \ub2f9\uad6d\uc774 \ud76c\uadc0 \uc9c8\ud658 \uce58\ub8cc\ub97c \uc704\ud55c \ubd84\uc0b0\ud615 \uce58\ub8cc \ubaa8\ub378\uc5d0 \uc775\uc219\ud574\uc9d0\uc5d0 \ub530\ub77c \uac00\uc815 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8\ub294 \ub354\uc6b1 \ud655\ub300\ub420 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4 \ubd84\uc11d<\/p>\n<p>\ubd81\ubbf8\ub294 \uac15\ub825\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc138\uae08 \uacf5\uc81c, FDA\uc758 \uc2e0\uc18d \uc2b9\uc778 \uba54\ucee4\ub2c8\uc998, \uad11\ubc94\uc704\ud55c \uc0c1\uc5c5 \ubcf4\ud5d8 \uc801\uc6a9 \ub355\ubd84\uc5d0 2025\ub144 \ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c 37.25%\uc758 \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc720\uc804\uc790 \uce58\ub8cc \ud65c\ub3d9\uc740 \uc8fc\ub85c \ubbf8\uad6d\uc5d0 \uc9d1\uc911\ub418\uc5b4 \uc788\uc73c\uba70, FDA\ub294 RGX-121\uc758 BLA(\uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ud5c8\uac00 \uc2e0\uccad) \uc0ac\uc804 \ud68c\uc758\uc5d0\uc11c \ub1cc\ucc99\uc218\uc561 \ud5e4\ud30c\ub780 \ud669\uc0b0\uc5fc \uac10\uc18c\ub97c \uc784\uc0c1\uc801 \uc774\uc810\uc758 \ub300\ub9ac \uc9c0\ud45c\ub85c \uc778\uc815\ud588\uc2b5\ub2c8\ub2e4. \uc778\ud50c\ub808\uc774\uc158 \uac10\ucd95\ubc95(IRA)\uc740 \uc7a5\uae30\uc801\uc778 \uac00\uaca9 \ucc45\uc815\uc5d0 \ubd88\ud655\uc2e4\uc131\uc744 \uc57c\uae30\ud558\uc9c0\ub9cc, \ud604\uc7ac \ubc95\uc548 \ucd08\uc548\uc740 \ub2e8\uc77c \uc801\uc751\uc99d \ud76c\uadc0\uc758\uc57d\ud488\uc744 \uba54\ub514\ucf00\uc5b4 \ud611\uc0c1\uc5d0\uc11c \uc81c\uc678\ud558\uc5ec \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9 \ucc45\uc815\uc758 \uc5ec\uc9c0\ub97c \ub0a8\uaca8\ub450\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc720\ub7fd\uc740 EMA\ub97c \ud1b5\ud55c \uac04\uc18c\ud654\ub41c \uc911\uc559 \uc9d1\uc911\uc2dd \uc2b9\uc778\uc744 \uc81c\uacf5\ud558\uc9c0\ub9cc, \uad6d\uac00\ubcc4 \uc0c1\ud658 \uc774\uc9c8\uc131\uc73c\ub85c \uc778\ud574 \uc811\uadfc\uc131\uc774 \ubd84\uc5f4\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. \uc11c\uc720\ub7fd \uad6d\uac00\ub4e4\uc740 \uc2dc\ud310 \ud5c8\uac00 \ud6c4 12\uac1c\uc6d4 \uc774\ub0b4\uc5d0 \uace0\uac00 \ud76c\uadc0\uc758\uc57d\ud488\uc744 \uc0c1\ud658\ud558\ub294 \ubc18\uba74, \uc911\ub3d9\ubd80 \uc720\ub7fd \uc2dc\uc7a5\uc740 2~3\ub144 \uc9c0\uc5f0\ub418\ub294 \uacbd\uc6b0\uac00 \ub9ce\uc2b5\ub2c8\ub2e4. \uc81c\uc548\ub41c \uc720\ub7fd \ud76c\uadc0 \uc720\uc804\uccb4 \uce58\ub8cc \uae30\uae08\uc740 EU \ucc28\uc6d0\uc5d0\uc11c \uc704\ud5d8\uc744 \uacf5\uc720\ud558\uace0 \uc131\uacfc \uae30\ubc18 \uacc4\uc57d\uc744 \ud611\uc0c1\ud568\uc73c\ub85c\uc368 \uc774\ub7ec\ud55c \uaca9\ucc28\ub97c \ud574\uc18c\ud558\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4. \ud504\ub791\uc2a4, \ub3c5\uc77c, \uc601\uad6d \uc13c\ud130\ub4e4\uc774 \ud5cc\ud130 \uc99d\ud6c4\uad70 \uc720\uc804\uc790 \uce58\ub8cc\ub97c \uc704\ud55c \uc720\ub7fd \uc784\uc0c1 \uc2dc\ud5d8\uc758 \uc808\ubc18 \uc774\uc0c1\uc744 \uc9c4\ud589\ud558\uba70 \ud559\uacc4-\uc0b0\uc5c5 \ucee8\uc18c\uc2dc\uc5c4\uc774 \uc5ec\uc804\ud788 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4.<\/p>\n<p>\uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591\uc740 2031\ub144\uae4c\uc9c0 8.08%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc73c\ub85c, \uc758\ub8cc \uc778\ud504\ub77c \uac15\ud654\uc640 \ud76c\uadc0 \uc9c8\ud658 \uc815\ucc45 \ud655\uc0b0\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \uc77c\ubcf8\uc740 2024\ub144 \uccab BBB \ud22c\uacfc ERT\ub97c \uc2b9\uc778\ud558\uace0 \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc11c\ub958\ub97c \uc2e0\uc18d\ud558\uac8c \ucc98\ub9ac\ud558\uae30 \uc704\ud55c \ud611\uc815\uc744 \uccb4\uacb0\ud558\uc5ec \ub2e4\uad6d\uc801 \uae30\uc5c5\uc758 \uc9c0\uc5ed\uc801 \uad00\uc2ec\uc744 \uc720\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc911\uad6d\uc740 2025\ub144 \uad6d\uac00 \ud76c\uadc0 \uc9c8\ud658 \ubaa9\ub85d\uc5d0 \ubba4\ucf54\ub2e4\ub2f9\uc99d II\ud615\uc744 \ud3ec\ud568\uc2dc\ucf1c \uc9c0\ubc29 \uc0c1\ud658 \uc2dc\ubc94 \uc0ac\uc5c5\uc744 \uc2dc\uc791\ud558\uace0 \uc9c4\ub2e8\uc728\uc744 \ub192\uc600\uc2b5\ub2c8\ub2e4. \uc778\ub3c4\ub294 2023\ub144 10% \ubbf8\ub9cc\uc774\ub358 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \uc801\uc6a9\ub960\uc744 40% \uc774\uc0c1\uc73c\ub85c \ud655\ub300\ud558\ub294 \uc8fc \ucc28\uc6d0\uc758 \ud504\ub85c\uadf8\ub7a8\uc744 \uc2dc\ud589\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uac1c\ud601\ub4e4\uc740 \ud658\uc790 \ud480\uc744 \ud655\ub300\ud558\uace0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed \ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc9c0\uc18d\uc801\uc778 \ub450 \uc790\ub9bf\uc218 \uc131\uc7a5\uc744 \uc704\ud55c \ubc1c\ud310\uc744 \ub9c8\ub828\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubc0f \uc8fc\uc694 \uae30\uc5c5<\/p>\n<p>\ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. Takeda\uc758 ELAPRASE \ud504\ub79c\ucc28\uc774\uc988\ub294 2024 \ud68c\uacc4\uc5f0\ub3c4\uc5d0 916\uc5b5 \uc5d4(6\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec)\uc758 \ub9e4\ucd9c\uc744 \uae30\ub85d\ud558\uba70 \uae30\uc874 ERT \ubd84\uc57c\uc5d0\uc11c \ud68c\uc0ac\uc758 \ub9ac\ub354\uc2ed\uc744 \ud655\uace0\ud788 \ud588\uc2b5\ub2c8\ub2e4. REGENXBIO, Denali Therapeutics, JCR Pharmaceuticals\ub294 \uac01\uac01 CNS \ud22c\uacfc\uc131 \uce58\ub8cc\ubc95\uc5d0 \ub300\ud55c \ucd5c\ucd08 \uc2b9\uc778\uc744 \ud655\ubcf4\ud558\uae30 \uc704\ud574 \uacbd\uc7c1\ud558\uba70 \uc720\uc804\uc790 \uce58\ub8cc \ubb3c\uacb0\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. Denali\uc758 tividenofusp alfa\ub294 1\/2\uc0c1 \uc5f0\uad6c\uc5d0\uc11c \uc9c0\uc18d\uc801\uc778 \uc778\uc9c0 \uac1c\uc120\uc744 \ubcf4\uc778 \ud6c4 2025\ub144 1\uc6d4 FDA\ub85c\ubd80\ud130 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc804\ub7b5\uc801 \uc81c\ud734\ub294 \uc0c1\uc5c5\uc801 \ubc0f \uc81c\uc870 \uc704\ud5d8\uc744 \uc644\ud654\ud569\ub2c8\ub2e4. REGENXBIO\uc640 Nippon Shinyaku\uc758 1\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec \uc120\ubd88 \ud30c\ud2b8\ub108\uc2ed\uc740 \ucd5c\ub300 7\uc5b5 \ub2ec\ub7ec\uc758 \uc7a0\uc7ac\uc801 \ub9c8\uc77c\uc2a4\ud1a4\uc744 \ud3ec\ud568\ud558\uba70 \uc77c\ubcf8 \ud30c\ud2b8\ub108\uc5d0\uac8c \uc9c0\uc5ed \uad8c\ud55c\uc744 \ubd80\uc5ec\ud558\uc5ec \ubb38\ud654\uc801\uc73c\ub85c \uc801\ud569\ud55c \uc2dc\uc7a5 \uc811\uadfc\uc744 \ubcf4\uc7a5\ud569\ub2c8\ub2e4. JCR Pharmaceuticals\ub294 Medipal Holdings\uc640 \ud611\ub825\ud558\uc5ec \ub3d9\uc544\uc2dc\uc544 \uc720\ud1b5\uc744 \uac04\uc18c\ud654\ud558\uace0 \uc788\uc73c\uba70, Ultragenyx\ub294 WuXi Advanced Therapies\uc640 \uacf5\uae09 \uacc4\uc57d\uc744 \uccb4\uacb0\ud558\uc5ec \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \uc0dd\uc0b0 \ub2a5\ub825\uc744 \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc6c0\uc9c1\uc784\uc740 \uc81c\uc870 \uaddc\ubaa8\uc640 \ud604\uc9c0 \uaddc\uc81c \uc804\ubb38\uc131\uc774 \ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \uacbd\uc7c1 \uc6b0\uc704 \uc694\uc18c\uac00 \ub418\uc5c8\uc74c\uc744 \uac15\uc870\ud569\ub2c8\ub2e4.<\/p>\n<p>\ub77c\ud2f4 \uc544\uba54\ub9ac\uce74\uc640 \uc911\ub3d9\uc5d0\uc11c\ub294 \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \uc778\ud504\ub77c\uac00 \uad6c\ucd95\ub418\uace0 \ucd08\ud76c\uadc0 \uc9c8\ud658\uc5d0 \ub300\ud55c \uc0c1\ud658 \ud504\ub808\uc784\uc6cc\ud06c\uac00 \uc544\uc9c1 \ubbf8\uac1c\ubc1c \uc0c1\ud0dc\uc774\ubbc0\ub85c \ubbf8\uac1c\ucc99 \uae30\ud68c\uac00 \uc874\uc7ac\ud569\ub2c8\ub2e4. \uacc4\uce35\ubcc4 \uac00\uaca9 \ucc45\uc815 \ubc0f \uc704\ud5d8 \uacf5\uc720 \ubaa8\ub378\uc744 \uac1c\ubc1c\ud560 \uc218 \uc788\ub294 \uae30\uc5c5\uc740 \uc120\uc810 \uc774\uc810\uc744 \ud655\ubcf4\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. 2025\ub144 \ud604\uc7ac \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc774\ub450\ub974\uc124\ud30c\uc81c \ud6c4\ubcf4 \ubb3c\uc9c8\uc740 \uc804\uc784\uc0c1 \ub2e8\uacc4\ub97c \ub118\uc5b4\uc120 \uac83\uc774 \uc5c6\uc5b4 Takeda\uc758 \uac00\uaca9 \uce68\uc2dd \ubc29\uc5b4\ub9c9\uc774 \uc720\uc9c0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uacbd\ub85c\uac00 \uc131\uc219\ud574\uc9c0\uba74 \uac00\uaca9 \uacbd\uc7c1\uc774 \uc2ec\ud654\ub418\uc5b4 \uae30\uc874 ERT\uc758 \ub9c8\uc9c4\uc744 \uc555\ubc15\ud560 \uc218 \uc788\uc9c0\ub9cc, \uc7a0\uc7ac\uc801\uc73c\ub85c \ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc804\uccb4 \uaddc\ubaa8\uc640 \uac00\uce58\ub97c \ud655\ub300\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc0b0\uc5c5 \ub3d9\ud5a5:<\/p>\n<p>*   2025\ub144 2\uc6d4: Avrobio\ub294 \ubba4\ucf54\ub2e4\ub2f9\uc99d II\ud615 \uce58\ub8cc\ub97c \uc704\ud55c \uc720\uc804\uc790 \uce58\ub8cc\uc81c AVR-RD-05\uac00 \ubbf8\uad6d FDA\ub85c\ubd80\ud130 \ud76c\uadc0\uc758\uc57d\ud488 \uc9c0\uc815\uc744 \ubc1b\uc558\ub2e4\uace0 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 1\uc6d4: REGENXBIO\uc640 Nippon Shinyaku\ub294 \uc77c\ubcf8\uc5d0\uc11c RGX-121(MPS II) \ubc0f RGX-111(MPS I)\uc744 \uc0c1\uc5c5\ud654\ud558\uae30 \uc704\ud55c \ub3c5\uc810 \ud30c\ud2b8\ub108\uc2ed\uc744 \uccb4\uacb0\ud588\uc73c\uba70, 1\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\uc758 \uc120\ubd88\uae08\uacfc \ucd5c\ub300 7\uc5b5 \ub2ec\ub7ec\uc758 \ub9c8\uc77c\uc2a4\ud1a4\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<br \/>\n*   2025\ub144 1\uc6d4: Denali\uc758 tividenofusp alfa\ub294 104\uc8fc \ub3d9\uc548 \ub1cc\ucc99\uc218\uc561 \ud5e4\ud30c\ub780 \ud669\uc0b0\uc5fc\uc744 90% \uc9c0\uc18d\uc801\uc73c\ub85c \uac10\uc18c\uc2dc\ud0a8 \ud6c4 FDA\ub85c\ubd80\ud130 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 12\uc6d4: FDA\ub294 ALHEMO(concizumab-mtci)\ub97c \uc2b9\uc778\ud558\uace0 \ud76c\uadc0 \uc18c\uc544 \uc9c8\ud658 \uc6b0\uc120 \uc2ec\uc0ac \ubc14\uc6b0\ucc98\ub97c \ubc1c\ud589\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacb0\ub860\uc801\uc73c\ub85c, \ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc740 \ud76c\uadc0\uc758\uc57d\ud488\uc5d0 \ub300\ud55c \uac15\ub825\ud55c \uc9c0\uc6d0\uacfc \ud601\uc2e0\uc801\uc778 \uc720\uc804\uc790 \uce58\ub8cc\uc81c \ubc0f BBB \ud22c\uacfc ERT\uc758 \uac1c\ubc1c\uc5d0 \ud798\uc785\uc5b4 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc785\ub2c8\ub2e4. \uce58\ub8cc \ube44\uc6a9 \ubc0f \uc811\uadfc\uc131 \ubb38\uc81c\ub294 \uc5ec\uc804\ud788 \uacfc\uc81c\ub85c \ub0a8\uc544\uc788\uc9c0\ub9cc, \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud655\ub300\uc640 \uac00\uc815 \uc8fc\uc785 \ubaa8\ub378\uc758 \ud655\uc0b0\uc740 \uc2dc\uc7a5\uc758 \uae0d\uc815\uc801\uc778 \uc804\ub9dd\uc744 \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4. \ubd81\ubbf8\uac00 \ud604\uc7ac \uc2dc\uc7a5\uc744 \uc8fc\ub3c4\ud558\uace0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc740 \uc804\ub7b5\uc801 \uc81c\ud734\ub97c \ud1b5\ud574 \uacbd\uc7c1 \uc6b0\uc704\ub97c \ud655\ubcf4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ud5cc\ud130 \uc99d\ud6c4\uad70(\ubba4\ucf54\ub2e4\ub2f9\uc99d II\ud615, MPS II) \uce58\ub8cc \uc2dc\uc7a5 \ubcf4\uace0\uc11c\ub294 \ud76c\uadc0 \uc9c8\ud658\uc778 \ud5cc\ud130 \uc99d\ud6c4\uad70\uc5d0 \ub300\ud55c \uc2ec\uce35\uc801\uc778 \uc2dc\uc7a5 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ud5cc\ud130 \uc99d\ud6c4\uad70\uc740 \ub9ac\uc18c\uc880 \ud6a8\uc18c \ub610\ub294 \uc774\ub450\ub85c\ub124\uc774\ud2b8-2-\uc124\ud30c\ud0c0\uc81c \ud6a8\uc18c \uacb0\ud54d\uc73c\ub85c \uc778\ud574 \ubc1c\uc0dd\ud558\ub294 \uc720\uc804 \uc9c8\ud658\uc73c\ub85c, \ud6a8\uc18c \ub300\uccb4 \uc694\ubc95(ERT)\uacfc \uc870\ud608\ubaa8\uc138\ud3ec \uc774\uc2dd(HSCT)\uc774 \uc8fc\uc694 \uce58\ub8cc\ubc95\uc73c\ub85c \ud65c\uc6a9\ub429\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 \uc99d\uc0c1 \uc644\ud654 \ubc0f \ud569\ubcd1\uc99d \uad00\ub9ac\uc5d0 \uc911\uc810\uc744 \ub454 \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \ud604\ud669\uacfc \ubbf8\ub798 \uc804\ub9dd\uc744 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \uc8fc\uc694 \uc694\uc778:<br \/>\n\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \ub3d9\uc778\uc73c\ub85c\ub294 \uac15\ub825\ud55c \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c \ubc0f \uac00\uaca9 \uacb0\uc815\ub825, \uac01\uad6d \uc815\ubd80\uc758 \ud76c\uadc0 \uc9c8\ud658 \uc5f0\uad6c \ubc0f \uce58\ub8cc \uc790\uae08 \uc9c0\uc6d0 \ud504\ub85c\uadf8\ub7a8 \ud655\ub300, BBB(\ud608\ub1cc\uc7a5\ubcbd) \ud22c\uacfc\uc131 ERT(\uc608: \ud30c\ube44\ub098\ud478\uc2a4\ud504 \uc54c\ud30c)\uc758 \uc0c1\uc5c5\uc801 \ucd9c\uc2dc, AAV9 \ubc0f LV \uae30\ubc18 \uc720\uc804\uc790 \uce58\ub8cc \ud30c\uc774\ud504\ub77c\uc778\uc758 \uac00\uc18d\ud654, MPS II\uc5d0 \ub300\ud55c \uc2e0\uc0dd\uc544 \uc120\ubcc4 \uac80\uc0ac \ud328\ub110 \ud3ec\ud568 \ud655\ub300, \uadf8\ub9ac\uace0 \uc7ac\ud0dd \uc8fc\uc785 \uc11c\ube44\uc2a4 \ubaa8\ub378\uc758 \uc131\uc7a5\uc774 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc694\uc778\ub4e4\uc740 \ud658\uc790 \uc811\uadfc\uc131\uc744 \ub192\uc774\uace0 \uce58\ub8cc \uc635\uc158\uc744 \ub2e4\uc591\ud654\ud558\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \ub192\uc740 \uc5f0\uac04 \uce58\ub8cc \ube44\uc6a9\uacfc \ubcf4\ud5d8 \uc0c1\ud658 \ub9c8\ucc30, \uc815\ub9e5 \uc8fc\uc0ac ERT\uc758 \uc81c\ud55c\uc801\uc778 \uc911\ucd94\uc2e0\uacbd\uacc4(CNS) \ud6a8\ub2a5, \ub9e4\uc6b0 \uc801\uc740 \ud658\uc790 \ud480\ub85c \uc778\ud55c \uc2e0\uaddc \uc9c4\uc785 \uae30\uc5c5\uc758 \ud22c\uc790 \uc218\uc775\ub960(ROI) \ud55c\uacc4, \uadf8\ub9ac\uace0 \uc735\ud569 \ub2e8\ubc31\uc9c8 \uc0dd\uc0b0\uc744 \uc704\ud55c \uc0dd\ubb3c\ud559\uc801 \uc81c\uc870 \ubcd1\ubaa9 \ud604\uc0c1\uc774 \uc9c0\uc801\ub429\ub2c8\ub2e4. \ub610\ud55c, \ubcf4\uace0\uc11c\ub294 \uacf5\uae09\ub9dd \ubd84\uc11d, \uaddc\uc81c \ud658\uacbd, \uae30\uc220 \uc804\ub9dd \ubc0f \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uad6c\uc870\uc801 \ud2b9\uc131\uc744 \uc2ec\uce35\uc801\uc73c\ub85c \ud0d0\uad6c\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<br \/>\n\ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc740 2026\ub144 14\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 18\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uce58\ub8cc \uc720\ud615\ubcc4\ub85c\ub294 \ud6a8\uc18c \ub300\uccb4 \uc694\ubc95(ERT)\uc774 2025\ub144 \ub9e4\ucd9c\uc758 81.35%\ub97c \ucc28\uc9c0\ud558\uba70 \uc2dc\uc7a5\uc744 \uc9c0\ubc30\ud558\uace0 \uc788\uc73c\uba70, \ud2b9\ud788 Takeda\uc758 ELAPRASE \ud504\ub79c\ucc28\uc774\uc988\uac00 \uc120\ub450\ub97c \ub2ec\ub9ac\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ubd80\ubb38\uc740 BBB \ud22c\uacfc\uc131 ERT \ubc0f AAV \uae30\ubc18 \uc720\uc804\uc790 \uce58\ub8cc\uc758 \ubc1c\uc804 \ub355\ubd84\uc5d0 \uc5f0\ud3c9\uade0 7.06%\uc758 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\ub294 \uc720\uc804\uc790 \ubc0f \uae30\ud0c0 \ucca8\ub2e8 \uce58\ub8cc\ubc95\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4\ub85c\ub294 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uc9c4\ub2e8 \ubc0f \ubcf4\ud5d8 \uc0c1\ud658 \uccb4\uacc4\uac00 \uc131\uc219\ud568\uc5d0 \ub530\ub77c 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 8.08%\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ucd5c\uc885 \uc0ac\uc6a9\uc790 \uce21\uba74\uc5d0\uc11c\ub294 \uc7ac\ud0dd \uc8fc\uc785 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9\uc774 \uc2dc\uc124 \ube44\uc6a9\uc744 \uc808\uac10\ud558\uba74\uc11c\ub3c4 \uc784\uc0c1 \uacb0\uacfc\ub97c \uc720\uc9c0\ud560 \uc218 \uc788\uc5b4 \uc5f0\ud3c9\uade0 6.21%\uc758 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654 \ubc0f \uacbd\uc7c1 \ud658\uacbd:<br \/>\n\ubcf8 \ubcf4\uace0\uc11c\ub294 \uce58\ub8cc \uc720\ud615(\ud6a8\uc18c \ub300\uccb4 \uc694\ubc95, \uc870\ud608\ubaa8\uc138\ud3ec \uc774\uc2dd, \uc720\uc804\uc790 \ubc0f \uae30\ud0c0 \ucca8\ub2e8 \uce58\ub8cc\ubc95), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ubcd1\uc6d0, \uc9c4\ub2e8 \ubc0f \ucc38\uc870 \uc5f0\uad6c\uc18c, \uc7ac\ud0dd \uc8fc\uc785 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \uc0c1\uc138\ud55c \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 Takeda Pharmaceutical Company Ltd., GC Pharma, JCR Pharmaceuticals Co. Ltd., REGENXBIO Inc. \ub4f1 \uc8fc\uc694 \uae00\ub85c\ubc8c \uae30\uc5c5 20\uacf3\uc758 \uc0ac\uc5c5 \uac1c\uc694, \uc7ac\ubb34, \uc81c\ud488 \ubc0f \uc804\ub7b5, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d\uc744 \ud3ec\ud568\ud55c \uc0c1\uc138\ud55c \ud504\ub85c\ud544\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc774\ub294 \uc2dc\uc7a5 \ub0b4 \uacbd\uc7c1 \uad6c\ub3c4\uc640 \uc8fc\uc694 \ud50c\ub808\uc774\uc5b4\ub4e4\uc758 \uc804\ub7b5\uc801 \uc6c0\uc9c1\uc784\uc744 \uc774\ud574\ud558\ub294 \ub370 \uc911\uc694\ud55c \uc815\ubcf4\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd:<br \/>\n\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5\uc758 \ubbf8\ucda9\uc871 \uc218\uc694(unmet need)\ub97c \ud3c9\uac00\ud558\uace0, \uc0c8\ub85c\uc6b4 \uce58\ub8cc\ubc95 \uac1c\ubc1c \ubc0f \uc2dc\uc7a5 \uc9c4\uc785 \uae30\ud68c\uc5d0 \ub300\ud55c \ud1b5\ucc30\ub825\uc744 \uc81c\uc2dc\ud558\uba70, \ud5cc\ud130 \uc99d\ud6c4\uad70 \uce58\ub8cc \uc2dc\uc7a5\uc758 \ubbf8\ub798 \ubc29\ud5a5\uc131\uc744 \uc870\ub9dd\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-59625","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/59625"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=59625"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/59625\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=59625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=59625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=59625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}